Strategic Partnerships Capitalize on current and announced alliances to offer joint R&D programs in AI-driven protein design for pharma and biotech. Target mid to large firms seeking faster discovery and scalable collaboration, leveraging BCR’s proprietary knowledge graph and AI stack as a differentiator.

Data Platform Access Position the Trillion Gene Atlas and BCR’s knowledge graph as a differentiated data platform for industry players needing scalable genotype-phenotype modeling. Offer data access, analytics as a service, and customized modeling partnerships to accelerate discovery and regulatory planning.

Gene Editing Services Market BCR’s AI models for programmable gene insertion and cell reprogramming to gene therapy developers. Propose design, validation planning, and rapid prototyping services, with milestone-based partnerships to de-risk early-stage programs.

Funding Collaboration Opportunities Leverage the London base and academic collaborations for funded R&D and joint proposals with government and research institutions. Offer sponsored research and grant-enabled programs to expand access to biotech markets and accelerate customer onboarding.

Compute Infrastructure Offer AI compute and data-infrastructure services aligned with NVIDIA-powered workflows and sequencing partners. Propose cloud or on-prem solutions, data pipeline design, and performance optimization to scale large-scale biological design projects.